IDO 抗体 (AA 78-184)
(1 reference)Quick Overview for IDO 抗体 (AA 78-184) (ABIN2475068)
抗原
See all IDO 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 78-184
-
交叉反应
- 小鼠
-
产品特性
- Purified IgG
-
纯化方法
- Purified
-
免疫原
- Peptide corresponding to amino acids 78-184 of human IDO fused to GST.
-
亚型
- IgG3
-
-
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 2-403) antibody
IDO 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 2-403) antibodyIDO 适用: 人 WB, IHC, IP, ICC 宿主: 小鼠 Monoclonal C13 unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 106-190) antibodyIDO 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 276-360) antibodyIDO 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (AA 26-199) antibodyIDO 适用: 小鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Indoleamine 2,3-Dioxygenase (IDO) (N-Term) antibodyIDO 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.0 mg/mL
-
-
-
: "Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy." in: Nature medicine, Vol. 11, Issue 3, pp. 312-9, (2005) (PubMed).
-
: "Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy." in: Nature medicine, Vol. 11, Issue 3, pp. 312-9, (2005) (PubMed).
-
- IDO (Indoleamine 2,3-Dioxygenase (IDO))
-
别名
- INDOLEAMINE 2,3-DIOXYGENASE
-
基因ID
- 3620
-
UniProt
- P14902
抗原
-
